Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Based on this, the authors aimed to investigate whether vitamin D deficiency contributes to the development of certain neurological and non-neurological complications and worse clinical outcomes after SAH.

Source: Introduction. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Impact of vitamin D deficiency on clinical outcomes in non-traumatic subarachnoid hemorrhage: A single-center prospective cohort study

Source: Article title.

Demographic characteristics and medical history of patients were also recorded.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Impact of vitamin D deficiency on clinical outcomes in non-traumatic subarachnoid hemorrhage: A single-center prospective cohort study

Cohort study · Scientific Reports · 2026

Original publication title

Impact of vitamin D deficiency on clinical outcomes in non-traumatic subarachnoid hemorrhage: A single-center prospective cohort study

Dorottya Szántó; Béla Fülesdi; Lili Simon; László Novák; János Kappelmayer; Csilla Molnár

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

There is growing evidence that neuroinflammation and systemic inflammatory response following SAH have a major effect on patients’ outcomes. We hypothesized that due to the immunomodulating and neuroprotective properties, Vitamin D deficiency may contribute to unfavorable outcome in SAH patients. Consecutive patients admitted with acute non-traumatic SAH were prospectively included. Within 24 h of admission, serum 25(OH)vitamin D levels were measured. During the first 21 days after SAH, inflammatory markers were closely monitored, the development of any infectious complication was noted, and the onset of cerebral vasospasm was evaluated using transcranial color-coded Doppler.

New ischemic lesions on follow-up computed tomography imaging were also documented. Patients’ outcomes were assessed according to the modified Rankin Scale (mRS) and the Barthel’s Index on days 14, 30, and 90. Onehundred fifteen patients were included, of whom 61 were vitamin D deficient (VDD, serum vitamin D < 50 nmol/L) and 54 were vitamin D sufficient (VDS, serum vitamin D ≧ 50 nmol/L). The incidence of new ischemic lesions was significantly higher in the VDD group (VDD: 68.63% vs. VDS: 40.74%, p = 0.008).

The VDD group also had higher peaks in inflammatory markers and a tendency of higher incidence of infections (VDD: 42.62% vs. VDS: 24.07%, p = 0.057). A poor outcome, as defined by the mRS, was significantly more frequent among VDD patients (on day 90: VDD, 61.02% vs. VDS, 35.19%, p = 0.011). Our findings raise the potential harmful effects of D hypovitaminosis among patients with SAH. Vitamin D deficiency may contribute to greater inflammatory response and increased risk of secondary ischemia, infections, and poor clinical outcomes.

Further studies will show whether low vitamin D levels measured at admission are the consequence of SAH severity or whether pre-ictus hypovitaminosis also plays a role in determining the worse prognosis.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-026-38728-9.

Authors’ abstract

There is growing evidence that neuroinflammation and systemic inflammatory response following SAH have a major effect on patients’ outcomes. We hypothesized that due to the immunomodulating and neuroprotective properties, Vitamin D deficiency may contribute to unfavorable outcome in SAH patients. Consecutive patients admitted with acute non-traumatic SAH were prospectively included. Within 24 h of admission, serum 25(OH)vitamin D levels were measured. During the first 21 days after SAH, inflammatory markers were closely monitored, the development of any infectious complication was noted, and the onset of cerebral vasospasm was evaluated using transcranial color-coded Doppler.

New ischemic lesions on follow-up computed tomography imaging were also documented. Patients’ outcomes were assessed according to the modified Rankin Scale (mRS) and the Barthel’s Index on days 14, 30, and 90. Onehundred fifteen patients were included, of whom 61 were vitamin D deficient (VDD, serum vitamin D < 50 nmol/L) and 54 were vitamin D sufficient (VDS, serum vitamin D ≧ 50 nmol/L). The incidence of new ischemic lesions was significantly higher in the VDD group (VDD: 68.63% vs. VDS: 40.74%, p = 0.008).

The VDD group also had higher peaks in inflammatory markers and a tendency of higher incidence of infections (VDD: 42.62% vs. VDS: 24.07%, p = 0.057). A poor outcome, as defined by the mRS, was significantly more frequent among VDD patients (on day 90: VDD, 61.02% vs. VDS, 35.19%, p = 0.011). Our findings raise the potential harmful effects of D hypovitaminosis among patients with SAH. Vitamin D deficiency may contribute to greater inflammatory response and increased risk of secondary ischemia, infections, and poor clinical outcomes.

Further studies will show whether low vitamin D levels measured at admission are the consequence of SAH severity or whether pre-ictus hypovitaminosis also plays a role in determining the worse prognosis.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-026-38728-9.

Publication and source details

Original title: Impact of vitamin D deficiency on clinical outcomes in non-traumatic subarachnoid hemorrhage: A single-center prospective cohort study

Dorottya Szántó; Béla Fülesdi; Lili Simon; László Novák; János Kappelmayer; Csilla Molnár

Scientific Reports · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.University of Debrecen

Open access funding provided by University of Debrecen.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:10:26.566440+00:00

DOI: 10.1038/s41598-026-38728-9 · PMC12923900